2020欧洲甲状腺学会《影像引导下良性甲状腺结节热消融治疗临床实践指南》解读

热消融是甲状腺结节治疗领域颇受关注的新技术,目前已逐步得到应用。2020年欧洲甲状腺学会发布了《影像引导下良性甲状腺结节热消融治疗临床实践指南》,为临床相关人员提供了良性甲状腺结节热消融(TA)治疗方面详细、可靠的指导。熟悉该指南中介绍的TA技术、操作标准及甲状腺结节的治疗选择,对于合理应用TA具有现实意义。     

Microwave ablation of hepatocellular carcinoma

Although surgical resection is still the optimal treatment option for early-stage hepatocellular carcinoma (HCC) in patients with well compensated cirrhosis, thermal ablation techniques provide a valid non-surgical treatment alternative, thanks to their minimal invasiveness, excellent tolerability and safety profile, proven efficacy in local disease control, virtually unlimited repeatability and cost-effectiveness. Different energy sources are currently employed in clinics as physical agents for percutaneous or intra-surgical thermal ablation of HCC nodules. Among them, radiofrequency (RF) currents are the most used, while microwave ablations (MWA) are becoming increasingly popular. Starting from the 90s’, RF ablation (RFA) rapidly became the standard of care in ablation, especially in the treatment of small HCC nodules; however, RFA exhibits substantial performance limitations in the treatment of large lesions and/or tumors located near major heat sinks. MWA, first introduced in the Far Eastern clinical practice in the 80s’, showing promising results but also severe limitations in the controllability of the emitted field and in the high amount of power employed for the ablation of large tumors, resulting in a poor coagulative performance and a relatively high complication rate, nowadays shows better results both in terms of treatment controllability and of overall coagulative performance, thanks to the improvement of technology. In this review we provide an extensive and detailed overview of the key physical and technical aspects of MWA and of the currently available systems, and we want to discuss the most relevant published data on MWA treatments of HCC nodules in regard to clinical results and to the type and rate of complications, both in absolute terms and in comparison with RFA.     

Catheter ablation of the atrioventricular node using radiofrequency energy

Background: Catheter ablation of the atrioventricular (AV) junction using stored direct current (DC) energy from a standard DC Cardioverter defibrillator was first reported in 1982. Since then many patients have been treated using this procedure for refractory supraventricular arrhythmias, usually atrial fibrillation and flutter. Undesirable thermal effects such as barotrauma and arcing are largely responsible for complications associated with the use of DC energy. This report details our experience of catheter ablation of the AV junction using radiofrequency (RF) energy in a series of 30 consecutive patients. Methods: RF ablations were performed using steerable Mansfield (Webster Laboratories) 4 mm tipped electrodes and locally assembled RF energy delivery system. Results: The procedure was successful in 27/30 (90%) patients using RF energy, while three patients required DC energy to achieve successful AV junction ablation. General anaesthesia was required in nine patients, six of whom required this for cardioversion to sinus rhythm so that an adequate His Bundle spike could be recorded and three for DC ablation. Dual chamber permanent pacemakers with automatic mode switching were implanted in four patients who had paroxysmal atrial fibrillation or flutter and the remainder had ventricular rate responsive pacemakers. Conclusions: In patients with drug refractory paroxysmal atrial fibrillation and flutter and in patients with established atrial fibrillation where control of the ventricular rate is difficult, catheter ablation of the AV junction using RF energy is a safe and effective procedure with a high success rate.     

Comparison of Cryoballoon and Radiofrequency Ablation of Pulmonary Veins in 40 Patients with Paroxysmal Atrial Fibrillation: A Case‐Control Study

Introduction: Ablation of pulmonary veins (PV) is an established therapeutic option for patients with symptomatic drug‐refractory paroxysmal atrial fibrillation (AF). Radiofrequency (RF) is currently the most widespread energy source for PV ablation. Cryothermal energy applied with a cryoballoon technique as an alternative has recently evolved. Methods and Results: In a case‐control setting, we compared 20 patients with paroxysmal AF who underwent their first PV ablation with the cryoballoon technique to 20 matched patients with conventional RF ablation. In the case of persistent electrical potentials after cryoballoon ablation, it was combined with ablation with a conventional cryocatheter. All patients performed daily event recording for 3 months after ablation procedure. Ablation parameters and success rate after 3 and 6 months were compared. In the cryoballoon group, the overall success rate was 55% (50% in the cryoballoon only group [14 patients] and 66% in the combination group [6 patients]), as opposed to the RF group with 45%. AF episode burden was lower after cryoballoon ablation. There was no significant difference between cryoballoon and RF ablation regarding procedure parameters. In the cryoballoon group, 3 phrenic nerve palsies occurred using the 23 mm balloon that resolved spontaneously. Conclusion: PV ablation with the cryoballoon technique is feasible and seems to have a similar success rate in comparison to RF ablation. Procedure‐ and fluoroscopy duration are not longer than in conventional RF ablation.     

Biophysics of Ablation:

Introduction: The question of what happens to tissue during radiofrequency (RF) catheter ablation continues to be asked as we evolve into the use of newer delivery systems.
Methods and Results: Three assumptions are made about RF ablation. (1) Tissue injury is thermally mediated; (2) heat transfer in tissue should be a predictable biophysical phenomenon; and (3) large lesion technologies have more or less equivalent efficacies. Based on these assumptions, predictions are made and discussed. Many of the predictors were proven to be true while some surprisingly were not.
Conclusion: In conclusion, tissue-area injury occurs reproducibly at a temperature of about 50°C. Heat transfer in tissue is a predictable phenomenon. And finally, new technologies for large lesions are all effective, but greater surface area of ablation was achieved with a 10-mm tip and greater depth was achieved with a Chilli^® cooled ablation catheter.     

Atypical left atrial flutter after intraoperative radiofrequency ablation of chronic atrial fibrillation: successful ablation using three-dimensional electroanatomic mapping

Curative treatment of chronic atrial fibrillation (AF) remains a challenging task for electrophysiologists. Eliminating the initiating triggers by focal radiofrequency ablation in a subset of patients with paroxysmal AF and modifying the maintaining substrate by performing linear lesions within the left atrium in patients with prolonged episodes of AF are among the alternative approaches for management of these patients. Recently, a new intraoperative treatment procedure aimed at eliminating left atrial anatomic "anchor" reentrant circuits by induction of contiguous lesions using radiofrequency energy under direct vision was introduced. However, atypical left atrial flutter may occur during follow-up after intraoperative ablation of AF. These arrhythmias most likely are due to discontinuities in linear lesions; therefore, they can be successfully mapped and ablated in a subsequent percutaneous catheter ablation procedure. We report and discuss the case of a patient who underwent successful intraoperative ablation of chronic AF, but who developed atypical left atrial flutter postoperatively. Three-dimensional nonfluoroscopic electroanatomic mapping revealed a gap in the linear lesion line connecting the left upper and right upper pulmonary vein orifices. Ablation at the exit site of the breakthrough was successful.     

Transmembraneous Irrigation of Multipolar Radiofrequency Ablation Catheters: Induction of Linear Lesions Encircling the Pulmonary Vein Ostium Without the Risk of Coagulum Formation?

INTRODUCTION: Pulmonary vein (PV) isolation for the curative treatment of atrial fibrillation using conventional radiofrequency ablation (RF) catheters with the point by point technique is time consuming and carries a remaining risk for thrombembolic complications. AIMS OF THE STUDY: Aim of the present in vivo study was to evaluate feasibility and safety of a novel multipolar irrigated ablation catheter designed to create contiguous lesions encircling the PV ostium in a single ablation position. METHODS: The entire ablation section (tripolar, length of each electrode 22 mm, interelectrode distance 2 mm, helix radius: 9 and 10 mm) of the 7F RF catheter (Encirclr, Medtronic, MN, USA) was covered by a porous membrane (pore size 30 micron) providing continuous irrigation. The helical formed catheter was used in two different experimental settings. Initially, a thigh muscle preparation has been performed in 7 anesthetized sheep in order to evaluate the development of lesions at different power level (40-80 W) and RF duration (30-90 sec). The ablation catheter was placed at the surface of the thigh muscle in a perpendicular position (0.1 N contact pressure) and perfused with heparinized blood (250 ml/min, 37C degrees ). Irrigation was provided with a flow rate of 10 ml/min. The resulted lesion morphology was evaluated with regard to coagulum or crater formation and lesion depth and diameter. Subsequently in 9 anesthetized sheep intracardiac ablation has been achieved with 50 W and an irrigation flow of 10 ml/min. Transseptal puncture and RF ablations were guided using fluoroscopy and intracardiac echocardiography (ICE, Acuson, USA). Endpoint of the intracardiac RF applications was the reduction of local electrogram amplitude >50%. RF applications were achieved at both atrial appendages and in the orifices of the coronary sinus (CS), the vena cava inferior (VCI) and PV. Following RF ablation all animals were sacrificed and following in vivo staining (2% TTC) macroscopically and histologically investigations of the lesions were performed. RESULTS: At the thigh muscle preparation 57 RF applications have been performed. The lesion depth was homogeneous without gaps between the ablation electrodes. There was a significant increase comparing 30 with 90 sec of RF duration for 40, 50 and 60 W applications respectively: 40 W: 1.1 +/- 0.4 vs. 3.6 +/- 0.5; 50 W: 1.2 +/- 0.3 vs. 4.6 +/- 0.4 mm and 60 W: 2.6 +/- 0.6 vs. 4.8 +/- 0.5 mm. All applications with 80 W (n = 3) had to be terminated due to immediate increase of impedance >150 omega. Late impedance rises (>60 sec) without occurrence of coagulum formation have been observed in 1 out of 4 RF applications with 60 W.A total of 85 RF applications could be achieved intracardiacally in the right atrium (right atrial appendage n = 18, ostium of the coronary sinus n = 12, ostium of the inferior caval vein: n = 12) and in the left atrium (left atrial appendage: n = 15, ostium of the PV: n = 28). ICE guided positioning of the catheter and showed during all applications no coagulum formation at the electrode or impedance rise (>150 Omega). Reduction of local electrograms (>50%) were observed following 48 out 85 (56%) RF applications. The lesions showed a homogeneous depth of 4 +/- 2 mm and a width 5 +/- 2 mm at the surface. No charring or crater formation could be observed in any of the lesions. CONCLUSIONS: In the present in vivo studies it could be demonstrated that long irrigated ablation electrodes induce continuous lesions without the risk of thrombus formation at the electrode. Increase of RF duration from 30 to 90 seconds with power setting of 40-60 W, respectively, created deeper lesions without the risk of thrombus formation. Thus, the helical formed irrigated ablation catheter appears to be appropriate for simplified PV isolation.     

Interatrial septal tachycardias following atrial fibrillation ablation or cardiac surgery: Electrophysiological features and ablation outcomes

1. Download : Download high-res image (275KB)
2. Download : Download full-size image

Interatrial septal tachycardia (IAS-AT) represented 9% of organized atrial tachycardia (AT) following atrial fibrillation (AF) ablation or cardiac surgery referred for radiofrequency catheter ablation (RFCA). The majority (93%) were targeted from the superior interatrial septum (IAS) limbus and the remaining 7% from the inferior limbus (left). Multiple interatrial septal connections at the level of the superior (red dotted lines) and inferior limbus (red circle) (right) may provide the anatomic substrate for IAS-AT. BB = Bachmann bundle; ICV = inferior vena cava; LA = left atrium; LAA = left atrial appendage; LS = left superior pulmonary vein; RA = right atrium; RAA = right atrial appendage; RI = right inferior pulmonary vein; RS = right superior pulmonary vein; SCV = superior vena cava; SP = septopulmonary bundle. (Anatomic image reproduced with permission from Ho and Sanchez-Quintana.¹⁵)

     

Comparison of pulsed field ablation and cryoballoon ablation for pulmonary vein isolation

Introduction

Pulmonary vein isolation (PVI) remains the cornerstone in the treatment of atrial fibrillation (AF). PVI using cryoballoon (CB) technology has emerged as a standard procedure in many centers. Recently, pulsed field ablation (PFA) has been introduced and used to achieve PVI. First data show high acute and favorable long-term outcomes. So far, data comparing these new “single shot” devices are sparse. We sought to compare procedural and outcome data for first time PFA users versus CB in patients undergoing de novo PVI. Furthermore, potentially postprocedural discomfort and affection of autonomic ganglia were assessed.

Methods and Results

A retrospective analysis and comparison of all de novo PVIs with PFA and CB was performed. Furthermore, PFA PVI learning curve was evaluated. During follow-up, repeat outpatient visits and Holter electrocardiogram were performed to analyze arrhythmia-free survival. Discomfort analysis was obtained by prescribed analgesic medication within first 48 h after PVI. Potential changes in heart rate (HR) between baseline and at 3-month follow-up were evaluated. A total of 108 patients (54 PFA and 54 CB; PFA; 33 (30%) female) with paroxysmal and persistent AF were analyzed. Type of AF was comparable (Patients suffering from PAF: PFA: 16 (30%), CB: 17 (31%), p = 1.0). In 107 (99%) patients, successful PVI was achieved. Transient phrenic palsy omitted complete PVI in one CB patient. A trend for a shorter overall procedure duration was observed in the PFA group (PFA: 64.5 ± 17.5 min; CB: 73.0 ± 24.8 min; p = 0.07). Excluding LA mapping time (first 14 cases), procedure time was significantly shorter using PFA (PFA: 58.0 ± 12.5 min, CB: 73.0 ± 24.8 min, p = 0.0001). Fluoroscopy time was significantly longer for PFA (PFA: 15.3 ± 4.7 min, CB: 12.3 ± 5.3 min; p = 0.001), but significantly less contrast medium was used (PFA: 12 ± 6 mL; CB: 51 ± 29 mL, p < 0.0001). Subgroup analysis of the PFA group revealed a significant shortening of procedure duration over time (first tertile: 72.7 ± 13.5 min, second tertile: 67.3 ± 21.7 min, third tertile: 53.4 ± 9.8 min, first vs. third tertile p < 0.0001). Two cardiac tamponades occurred in the PFA group (p = 0.495), of which one was most likely related to complex transseptal puncture. In the first 48 h after PVI, the number of prescribed analgesics due to postprocedural pain was equal between both groups (PFA: 7 (13%) patients, CB: 10 (19%) patients, p = 0.598). After a FU of 273 ± 129 days, 35 of 47 patients (74%) after PFA and 36 of 50 patients (72%) after CB PVI were free of any atrial arrhythmia (HR: 0.98, p = 0.88). Only in the PFA group, a significant increase in HR 3 months after PVI was observed (pre-PVI: 61 ± 8 beats/min, post-PVI: 65 ± 9 beats/min, p = 0.008).

Conclusion

The new PFA technology is equally effective and safe as compared to CB for complete PVI with potentially shorter procedure time and significantly less contrast medium. However, AF recurrence rates after PFA PVI seem to be comparable to CB PVI.     

Efficacy of a Microwave Antenna for Ablation of the Tricuspid Valve—Inferior Vena Cava Isthmus in Dogs as a Treatment for Type 1 Atrial Flutter

INTRODUCTION: Radiofrequency catheter ablation of the tricuspid valve-inferior vena cava (TV-IVC) isthmus for treatment of atrial flutter (AFL), may in some cases require a large number of energy applications and a long procedure and fluoroscopy time. AIMS OF STUDY: Therefore, we studied the safety and efficacy of a 4 cm long microwave antenna mounted on a steerable 9Fr catheter for linear ablation of the TV-IVC isthmus. METHODS: In 6 anesthetized dogs, multi-electrode catheters were positioned in the coronary sinus (decapolar), at the His bundle (quadripolar) and around the TV annulus (decapolar) for pacing and recording atrial activation sequences before and after ablation. The microwave antenna was then positioned across the TV-IVC isthmus from the TV annulus (identified by equal A and V potentials) to the inferior vena cava with slight traction on the catheter to ensure adequate endocardial contact. Microwave energy was then applied at a fixed power for 120 seconds during each ablation attempt. Ablation was repeated until bi-directional isthmus block was demonstrated during pacing from the coronary sinus ostium and low lateral right atrium, respectively. RESULTS: Linear microwave ablation of the TV-IVC isthmus was completed in all ten dogs using a total of 2.6 +/- 1.17 energy applications per dog. Power was applied in a range of 45-50 watts. There were no acute procedural complications. Bi-directional TV-IVC isthmus block was achieved in all ten dogs, as demonstrated by a strictly descending activation wavefront in the ipsilateral atrial wall, during pacing from the CSO and LLRA respectively. In addition, after ablation conduction time to the LLRA during pacing from the CSO increased from 52 +/- 16.62 before to 87 +/- 12.74 msec (p <.05), and to the CSO during pacing from the LLRA from 51 +/- 12.43 before to 79.50 +/- 9.85 msec (p <.05). Gross and histological examination of the TV-IVC isthmus after ablation revealed continuous transmural lesions, ranging from 3-5 mm in width, spanning the entire TV-IVC isthmus in all ten dogs. CONCLUSIONS: (1) Microwave ablation of the TV-IVC isthmus was safe and effective in this study. (2) Ablation of the entire width and thickness of the TV-IVC isthmus can be rapidly achieved using a long microwave antenna in a fixed trans-isthmus position.     

Technical and safety performance of CT-guided percutaneous microwave ablation for lung tumors: an ablate and resect study

BackgroundPercutaneous image-guided thermal ablation has an increasing role in the treatment of primary and metastatic lung tumors. Achieving acceptable clinical outcomes requires better tools for pre-procedure prediction of ablation zone size and shape.MethodsThis was a prospective, non-randomized, single-arm, multicenter study conducted by Medtronic (ClinicalTrials.gov ID: {"type":"clinical-trial","attrs":{"text":"NCT02323854","term_id":"NCT02323854"}}NCT02323854). Subjects scheduled for resection of metastatic or primary lung nodules underwent preoperative percutaneous microwave ablation. Ablation zones as measured via CT imaging following ablation immediately and before resection surgically versus predicted ablation zones as prescribed by the investigational system software were compared. This CT scan occurred after the ablation was finished but the antenna still in position. Time (minutes) from antenna placement to removal was 23.7±13.1 (n=14); median: 21.0 (range, 6.0 to 48.0). The definition of the secondary endpoint of complete ablation was 100% non-viable tumor cells based on nicotinamide adenine dinucleotide hydrogen (NADH) staining. Safety endpoints were type, incidence, and severity of adverse events.ResultsFifteen patients (mean age 58.9 years; 67% male; 33% female) were enrolled in the study, 33.3% (5/15) with previous thoracic surgery, 73% (11/15) with metastasis, and 27% (4/15) with primary lung tumors. All underwent percutaneous microwave ablation followed by surgical resection the same day. Complete ablation was detected in 54.4% (6/11), incomplete ablation in 36.4% (4/11), and delayed necrosis in 9.1% (1/11). There were no device-related adverse events. Ablation zone volume was overestimated in all patients.ConclusionsHistological complete ablation was observed in 55% of subjects. CT scanning less than an hour after ablation and tissue shrinkage may account for the smaller zone of ablation observed compared to predicted by the investigational system software.     

点消融和线性消融治疗典型心房扑动的对比研究

目的:采用点消融三尖瓣峡部的方法治疗典型心房扑动,并对比常规线性消融,证实点消融治疗典型心房扑动的可行性。方法:14例典型心房扑动病人分为线性消融组(A组)与点消融组(B组),分别比较2组下腔静脉与三尖瓣峡部双向阻滞的手术时间、X线照射时间、放电次数、手术费用、复发率。结果:点消融组病人的手术时间、X线照射时间短,放电次数少,手术费用低(P<0．01),2组均无心包填塞、三度房室传导阻滞以及栓塞等并发症,复发率没有统计学差异。结论:点消融是一种值得进一步推广的治疗典型心房扑动的方法。     

射频导管消融房室结改良术心电监测分析

为探讨射频导管消心室改良术所致心律失常的发生规律，分析射频导管消融房室结改良术２２例术中及术后２４ｈ的心电监测资料，并与预激旁道消融术２２例进行对比研究。